MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

10 Aug 2024 Evaluate
Net sales declined -12.50%  to  Rs. 101.34 million from Rs. 115.82 millions.The Company to register a -30.35%  fall in the net profit for the quarter ended June 2024.Operating profit for the quarter ended June 2024 decreased to 43.88 millions as compared to 46.00 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 101.34 115.82 -12.50 101.34 115.82 -12.50 448.81 516.22 -13.06
Other Income 0.12 0.00 0.00 0.12 0.00 0.00 0.39 0.36 8.33
PBIDT 43.88 46.00 -4.61 43.88 46.00 -4.61 211.23 215.23 -1.86
Interest 19.24 19.47 -1.18 19.24 19.47 -1.18 77.78 76.51 1.66
PBDT 24.64 26.53 -7.12 24.64 26.53 -7.12 133.45 138.72 -3.80
Depreciation 22.29 22.85 -2.45 22.29 22.85 -2.45 92.91 92.66 0.27
PBT 2.35 3.68 -36.14 2.35 3.68 -36.14 40.54 46.06 -11.98
TAX 0.56 1.11 -49.55 0.56 1.11 -49.55 15.33 19.72 -22.26
Deferred Tax -1.42 -0.61 132.79 -1.42 -0.61 132.79 -1.43 9.41 -115.20
PAT 1.79 2.57 -30.35 1.79 2.57 -30.35 25.21 26.34 -4.29
Equity 149.04 149.04 0.00 149.04 149.04 0.00 149.04 149.04 0.00
PBIDTM(%) 43.30 39.72 9.02 43.30 39.72 9.02 47.06 41.69 12.88
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..